Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
6.95
-0.05 (-0.71%)
Dec 31, 2025, 2:28 PM EST - Market open
Teladoc Health Revenue
Teladoc Health had revenue of $626.44M in the quarter ending September 30, 2025, a decrease of -2.20%. This brings the company's revenue in the last twelve months to $2.53B, down -2.37% year-over-year. In the year 2024, Teladoc Health had annual revenue of $2.57B, down -1.26%.
Revenue (ttm)
$2.53B
Revenue Growth
-2.37%
P/S Ratio
0.48
Revenue / Employee
$459,673
Employees
5,500
Market Cap
1.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.57B | -32.84M | -1.26% |
| Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
| Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
| Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
| Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
| Dec 31, 2019 | 553.31M | 135.40M | 32.40% |
| Dec 31, 2018 | 417.91M | 184.63M | 79.14% |
| Dec 31, 2017 | 233.28M | 110.12M | 89.42% |
| Dec 31, 2016 | 123.16M | 45.77M | 59.15% |
| Dec 31, 2015 | 77.38M | 33.86M | 77.78% |
| Dec 31, 2014 | 43.53M | 23.62M | 118.67% |
| Dec 31, 2013 | 19.91M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TDOC News
- 4 weeks ago - Teladoc Health, Inc. (TDOC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Teladoc Health to Participate in Upcoming Investor Conference - GlobeNewsWire
- 6 weeks ago - TytoCare Integrates With Teladoc Health to Augment Virtual Primary and Urgent Care - PRNewsWire
- 6 weeks ago - Teladoc Health: Fading Hope - Seeking Alpha
- 7 weeks ago - Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 - GlobeNewsWire
- 2 months ago - Teladoc Health, Inc. (TDOC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Teladoc Health Reports Third Quarter 2025 Results - GlobeNewsWire
- 2 months ago - These 3 stocks are primed for big moves after earnings this week - Invezz